Aurora Financial JournalNightingale Health (HEALTH.HE)
Nasdaq Helsinki · Financial statements, TTM figures and earnings dates
In fiscal year 2026 (ended June 30, 2026), Nightingale Health reported revenue of €5.5M and net income of −€18.5M. Annual financial statements are available for fiscal years 2024 to 2026, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| EUR | FY2026 2026-06-30 | FY2025 2025-06-30 | FY2024 2024-06-30 |
|---|---|---|---|
| Income statement | |||
| Revenue | €5.5M | €4.7M | €4.4M |
| Operating income | −€18.8M | −€19.4M | −€18.6M |
| Net income | −€18.5M | −€18.5M | −€17.5M |
| Cash flow | |||
| Operating cash flow | −€10.9M | −€10.1M | −€8.4M |
| Capital expenditure | €878.0K | €2.3M | €2.2M |
| Free cash flow | −€11.8M | −€12.4M | −€10.6M |
| Balance sheet | |||
| Cash and equivalents | €36.8M | €41.3M | €43.7M |
| Total assets | €58.1M | €74.5M | €90.8M |
| Total liabilities | €9.3M | €8.3M | €8.0M |
| Total debt | €0 | €261.0K | €827.0K |
| Shareholders' equity | €48.7M | €66.2M | €82.9M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in EUR as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full HEALTH.HE page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open HEALTH.HE financials →